To investigate the intra-ocular pressure ( IOP ) - lowering effects of a selective Rho kinase inhibitor , ripasudil ( K-@ ) , over @ hr in patients with primary open-angle glaucoma ( POAG ) or ocular hypertension ( OHT ) .